1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
(
- Contribution to journal › Article
- 2004
-
Mark
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
(
- Contribution to journal › Article
- 2003
-
Mark
Cyklofosfamid (CP) i urin vid riskvärdering vid cytostatikaarbete
2003) Svenska Läkaresällskapets Riksstämma, 2003(
- Contribution to conference › Abstract